OIS Podcast | Ophthalmology's leading Podcast
By OIS Podcast
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by OIS Podcast
Category: Investing
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 8
Reviews: 0
Episodes: 397
Description
Welcome to the Ophthalmology Innovation Podcast Where you get Candid Conversations with the Leaders and Drivers of Ophthalmic Innovation. OIS is the Largest and Original Producer of World-Class Ophthalmology Innovation Conferences and Content Since 2009.
| Episode | Date |
|---|---|
|
Exploring the FDA
|
Apr 26, 2024 |
|
Empathy in Action
|
Apr 12, 2024 |
|
From Ophthalmology Clinics to Business Leadership
|
Mar 29, 2024 |
|
Exploring the Future of Eye Care
|
Mar 15, 2024 |
|
5 Mistakes to Avoid in Biotech Investor Pitch Decks
|
Mar 01, 2024 |
|
Unlocking the Future of Presbyopia Treatment
|
Feb 16, 2024 |
|
Revolutionizing Ophthalmic Care
|
Feb 02, 2024 |
|
Insights from Startup Leaders on Commercial Strategy and Funding
|
Jan 19, 2024 |
|
Maximizing the Value of Your Board of Directors
|
Jan 05, 2024 |
|
Quick Takes From Ophthalmology Start-Ups
|
Dec 22, 2023 |
|
Revolutionizing Retina Care Beyond Injections
|
Dec 15, 2023 |
|
Revolutionizing Glaucoma Treatment and Innovation Insights
|
Dec 01, 2023 |
|
Ophthea's Transformative Shift, Clinical Successes, and Visionary Innovation
|
Nov 17, 2023 |
|
Building an Enterprise Under the Radar
|
Nov 03, 2023 |
|
Approachable Regenerative Medicine
|
Oct 20, 2023 |
|
The Bausch + Lomb Buzz, with Andrew Stewart and Yehia Hashad, MD
|
Oct 06, 2023 |
|
C-Suite Quick Takes: OIS Goes Behind the Scenes with Four Emerging Biotech Companies
|
Sep 22, 2023 |
|
CEO Quick Takes
|
Sep 08, 2023 |
|
The Latest on At-Home OCT
|
Aug 18, 2023 |
|
Accessing Charitable Resources
|
Aug 11, 2023 |
|
What’s New in Ocular Surface Disease?
|
Aug 04, 2023 |
|
Accessing Capital and Navigating M&As
|
Jul 28, 2023 |
|
When Is the Right Time to Form a Spin-Out? With Wesley Jackson, PhD, Valitor
|
Jul 21, 2023 |
|
Commercializing Demedex Blepharitis
|
Jul 14, 2023 |
|
From Lab Learning to Machine Learning, with Daniela Ferrara, Genentech
|
Jul 07, 2023 |
|
How Digital Innovation is Advancing Ophthalmology
|
Jun 30, 2023 |
|
Fueling the Innovation Engine, With Christoph Vonwiller, Johnson & Johnson Vision
|
Jun 23, 2023 |
|
Credibility, Cash, and Capability: The Benefits of Strategic Partnership, with Brian Culley, Lineage Cell Therapeutics
|
Jun 16, 2023 |
|
A Fast, Fun Future, with Warren Foust and Magda Michna, PhD, Staar Surgical
|
Jun 09, 2023 |
|
How Retina Physicians Can Use AI, With Natasa Jovic, RetinAI
|
May 19, 2023 |
|
The Inspiration Behind Syfovre, with Cedric Francois
|
May 05, 2023 |
|
Taking the Road Less Traveled, With Jod Mehta, Singapore National Eye Center
|
Apr 28, 2023 |
|
The 3 Ingredients of a Successful Dry Eye Product, With Barry Linder, MD, Eyedetec Medical
|
Apr 21, 2023 |
|
Meeting the Needs of Ophthalmic Surgeons, with Ed Timm, Mobius Therapeutics
|
Apr 14, 2023 |
|
Pharma’s All or None, with Gianluca Rossetti, Dompé
|
Apr 07, 2023 |
|
How Science Drives Decisions at Dompé, with Georgea Pasedis
|
Mar 31, 2023 |
|
How Bausch + Lomb Identifies Product Gaps, With Anthony Wallace
|
Mar 22, 2023 |
|
Ocular Surface Disease Spotlight
|
Mar 10, 2023 |
|
Spotlight on Myopia
|
Feb 24, 2023 |
|
Practicing and Advising on Medicine
|
Feb 17, 2023 |
|
Multimodal Myopia Management
|
Feb 10, 2023 |
|
Changing the Glaucoma Monitoring Paradigm
|
Feb 03, 2023 |
|
Metaverse Medicine
|
Jan 27, 2023 |
|
Perception, Vision, and Gaming
|
Jan 20, 2023 |
|
New Possibilities for Corneal Disease Treatment
|
Jan 13, 2023 |
|
Sit-downs with Eight OIS XII All-Stars
|
Dec 21, 2022 |
|
Expert Panel: How to Launch a Product
|
Dec 14, 2022 |
|
Setting the Standards in Imaging
|
Nov 30, 2022 |
|
From Leading Global R&D Teams to Funding Startups
|
Nov 23, 2022 |
|
The Potential of Entire-Eye OCT Imaging
|
Nov 16, 2022 |
|
Launching a Novel Dry Eye Product
|
Nov 09, 2022 |
|
Meeting China’s Unmet Need
|
Nov 02, 2022 |
|
The Game Changer
|
Oct 26, 2022 |
|
Spotlight on OIS Israel at MIXiii
|
Oct 19, 2022 |
|
Rayner’s Tim Clover on KOLs and IOLs
|
Oct 12, 2022 |
|
Glenn Tookey’s Mission Against Blindness
|
Sep 28, 2022 |
|
Democratizing Cell Therapy
|
Sep 21, 2022 |
|
Santen’s Dr. Sallstig on People, Passion, and Performance
|
Sep 14, 2022 |
|
Great Minds Think Differently
|
Aug 31, 2022 |
|
MedTech Ophthalmology European VC Panel
|
Aug 24, 2022 |
|
Flying Eye Hospitals and Machine Mentoring, with Orbis International
|
Aug 17, 2022 |
|
Early-Stage Retina Drug Development Financing
|
Aug 10, 2022 |
|
OIS Retina 2022: How to Execute New Treatments for Dry AMD and GA
|
Aug 03, 2022 |
|
Spotlight On Gene & Cell Therapy
|
Jul 27, 2022 |
|
Early-Stage Retina Drug Development Financing
|
Jul 20, 2022 |
|
Ashley Brissette, MD: Academic and Eye-Focused Skincare Entrepreneur
|
Jun 22, 2022 |
|
Inside the Ocular Biofactory, with Thomas Chalberg, PhD
|
Jun 15, 2022 |
|
Creating Synergies Between Portfolio Companies, with Yaacov Michlin, BioLight
|
Jun 08, 2022 |
|
Dr. Raj Agrawal’s Dual Missions
|
May 25, 2022 |
|
Roesky’s Quest: Durable Dry Eye Therapy
|
May 18, 2022 |
|
Seizing Opportunities with Novartis’ Dr. Jill Hopkins
|
May 11, 2022 |
|
Surfing Between Academic Medicine and Innovation with William Freeman, MD
|
May 04, 2022 |
|
Bilal Khan, New World Medical, on Balancing Mission with Profitability
|
Apr 27, 2022 |
|
Success From Failure With Iveric Bio’s Dr. Pravin Dugel
|
Apr 20, 2022 |
|
Treating ‘Lazy Eye’ with Screen Time
|
Apr 13, 2022 |
|
Tresserras’ Knack With Academic Assets
|
Mar 30, 2022 |
|
Setting Innovation Guideposts, with Manoj Vyas & Sanjeev Ganatra, CBCC Global Research
|
Mar 09, 2022 |
|
From Enterprise CEO to VC Founder, with Richel Liu
|
Feb 23, 2022 |
|
Solving the Presbyopia Problem, with Robin Sears
|
Feb 16, 2022 |
|
Trying It All and Succeeding, With Adrienne Graves
|
Feb 09, 2022 |
|
A Laser-Focused Business Model, with Nir Katchinskiy, PhD and Lahav Gil
|
Feb 02, 2022 |
|
The Coast to Coast Journey from Academic Research to Janssen Pharmaceuticals with Daniel Chao, MD, PhD
|
Jan 26, 2022 |
|
What’s New in Drug Delivery?
|
Jan 19, 2022 |
|
Passionate Pursuits, With Brian Strem, Kiora Pharmaceuticals
|
Jan 12, 2022 |
|
Visionary Ventures, with Lori-Ann Christie
|
Jan 05, 2022 |
|
Ophthalmology Innovation Year in Review
|
Dec 15, 2021 |
|
Treating the Untreatable Using Your Own Patient Experience, with Diana Driscoll, OD
|
Dec 08, 2021 |
|
Cracking the U.S. Dry Eye Market, With Brent Jones, CCO, I-MED Pharma
|
Nov 30, 2021 |
|
Moving From Medicine to Industry, With David Tanzer and Kerrie Brady
|
Nov 24, 2021 |
|
Faster, Better, Smarter, Cheaper, with Bill McPhee
|
Nov 17, 2021 |
|
Industry Insights on the Glaucoma Market from OIS Glaucoma Innovation Showcase
|
Nov 10, 2021 |
|
DIY Commercialization with Michael Gertner, MD
|
Nov 03, 2021 |
|
Change Creates Opportunity with Ramin Valian
|
Oct 27, 2021 |
|
Finding and Funding Assets in Retina, from OIS Retina@ASRS
|
Oct 20, 2021 |
|
The Next Cycle of Retinal Surgery Innovation, with Stanley Chang, MD
|
Oct 13, 2021 |
|
Solving the Dry Eye Mystery, With Jeffrey Krall, Neurolens
|
Oct 06, 2021 |
|
Following Intellectual Passions, With Dr. Baruch Kupperman
|
Sep 29, 2021 |
|
Revolutionizing Cataract Surgery from Innovation to Commercialization
|
Sep 22, 2021 |
|
From Big Pharma Lawyer to Eye Care Disruptor—IACTA Pharmaceuticals Founder & CEO Damon Burrows
|
Sep 15, 2021 |
|
Leading a Young Company with a Five-Generation History with Jean-Frédéric Chibret
|
Sep 08, 2021 |
|
Intimate Discussions from OIS Israel Innovation Showcase
|
Sep 01, 2021 |
|
Leading a Global Leader, with Pierre Billardon
|
Aug 25, 2021 |
|
Living the Dream with Donald Korb, OD
|
Aug 11, 2021 |
|
Discovering the Therapeutic Power of Collagen Mimetics
|
Aug 11, 2021 |
|
Developing a Clear Vision for a Clinical-Stage Company with Ben Bergo
|
Aug 04, 2021 |
|
Building a Best-in-Class Company for a Best-in-Class Therapy: LENZ Therapeutics CEO Eef Schimmelpennink
|
Jul 28, 2021 |
|
Balancing a Passion for Science & Business — Alcon’s Jeannette Bankes
|
Jul 21, 2021 |
|
The 3 T’s - Technique, Technology and Teaching with Steve Charles, MD
|
Jul 14, 2021 |
|
Paul Ryb, the Ability to Live & Succeed with Sight Loss
|
Jul 07, 2021 |
|
The Architect of Pharmaceuticals with Marc Gleeson, CEO of Azura Ophthalmics
|
Jun 30, 2021 |
|
Vision is Everything with Samsara’s Tom Ruggia
|
Jun 23, 2021 |
|
Zeiss Meditec’s Euan Thomson Says Data at Scale Will Enable New Insights in Healthcare
|
Jun 16, 2021 |
|
Roll Up Your Sleeves with Oyster Point’s John Snisarenko
|
Jun 09, 2021 |
|
B+L’s Chuck Hess is Looking to Change the Game in Ophthalmology
|
Jun 02, 2021 |
|
From Competitive Athlete To Pharma CEO
|
May 26, 2021 |
|
Fueled by Passion to Advance Development
|
May 19, 2021 |
|
Taking Alcon Back to Basics
|
May 12, 2021 |
|
Earning the Right to Ask for the Business with Nick Curtis of LENSAR
|
May 05, 2021 |
|
Drug Hunter by Day with Arthur Suckow, PhD
|
Apr 28, 2021 |
|
Dr. Bala Ambati Discusses The Long Journey from Idea to Impact
|
Apr 21, 2021 |
|
Building Value for Pipeline Assets with Mina Sooch
|
Apr 14, 2021 |
|
Paul Karpecki, OD, FAAO, Leads a Panel of Industry Experts in a Discussion on the Dry Eye Landscape
|
Mar 31, 2021 |
|
Ashley Brissette, MD Leads Discussion with KOLs on the Complexities and Management of Dry Eye Disease
|
Mar 24, 2021 |
|
Building Trust in Business
|
Mar 17, 2021 |
|
The Reversal of Age-Related Ophthalmic Disorders
|
Mar 10, 2021 |
|
KOLs Speak Out on the Future of Gene Therapy
|
Mar 03, 2021 |
|
The Sky’s the Limit with the Venerable Vince Anido
|
Feb 24, 2021 |
|
Dr. Cal Roberts’ Latest Leap to Lighthouse
|
Feb 17, 2021 |
|
The Vision of TearClear’s Future with CEO, Robert Dempsey
|
Feb 10, 2021 |
|
Navigating Regulatory Hurdles with Kim Brazzell, PhD
|
Feb 03, 2021 |
|
Banishing Bureaucracy at BVI
|
Jan 27, 2021 |
|
Invest in 2021 with the Best in Ophthalmic Business
|
Jan 20, 2021 |
|
Venturing into Ophthalmology with ExSight
|
Jan 13, 2021 |
|
Outlook’s Plan for Bevacizumab-vikg
|
Jan 06, 2021 |
|
A Vision for Business
|
Dec 23, 2020 |
|
OIS Industry Panel on Retina Start-ups
|
Dec 16, 2020 |
|
Investing in the Future of Ophthalmology
|
Dec 09, 2020 |
|
KOL Perspective on Glaucoma Therapies and Development
|
Dec 02, 2020 |
|
Discussion on Drug Delivery Technologies with Some of Pharma’s Best and Brightest Executives
|
Nov 25, 2020 |
|
Nature as an Inspiration for Innovation
|
Nov 18, 2020 |
|
A lot of Skill and a Little Bit of Luck
|
Nov 11, 2020 |
|
The Steve Jobs of Ophthalmology
|
Nov 04, 2020 |
|
Doctor to Doctor with President and CEO, Euclid Systems Corporation
|
Oct 28, 2020 |
|
An Intimate Look at the Future of Ocular Gene Therapy
|
Oct 21, 2020 |
|
A Stimulating Conversation with Patrik De Haes, MD - CEO at Oxurion
|
Oct 14, 2020 |
|
Tim Clover, CEO of Rayner Talks About the Company’s Deep History in Ophthalmology, As Well As Their Future Plans For Innovation
|
Oct 07, 2020 |
|
Impacting Lives Using Tomorrow's Technology
|
Sep 30, 2020 |
|
A Dynamic Career in Retina
|
Sep 23, 2020 |
|
Follow Your Passion
|
Sep 16, 2020 |
|
The Apprentice
|
Sep 09, 2020 |
|
Never Take No For An Answer
|
Sep 02, 2020 |
|
Listening to the Needs of the Customer
|
Aug 26, 2020 |
|
Treating Challenges as Opportunities
|
Aug 20, 2020 |
|
Au Petit Bonheur La Chance
|
Aug 13, 2020 |
|
The Lindstrom Method: Say ‘Yes’ to Opportunities
|
Aug 06, 2020 |
|
Dr. Ken Mandell’s Passion for Innovation
|
Jul 30, 2020 |
|
Paul Hallen’s View of Retina from the Catbird’s Seat
|
Jul 23, 2020 |
|
The Time is Nau!
|
Jul 15, 2020 |
|
OIS Israel Panel Dives Into Global Industry Insights and Innovation
|
Jul 09, 2020 |
|
From West Point to ONL’s C-Suite - David Esposito
|
Jul 02, 2020 |
|
John Hovanesian, MD, on Business, Life, Trends, IOL Technology, and More
|
Jun 25, 2020 |
|
OIS Retina Podcast: Interview with Serial Inventor Dr. Mark Humayun
|
Jun 18, 2020 |
|
Introducing the OIS Retina Podcast!
|
Jun 11, 2020 |
|
Bill Link’s Road to Ophthalmology and VC
|
Jun 04, 2020 |
|
Innovation Starts at Home (Updated)
|
May 29, 2020 |
|
Challenging Conventional Thinking with the Laws of Physics
|
May 14, 2020 |
|
Elad Kedar and Jeff Weinhuff Share the Recipe for Orasis Pharmaceuticals
|
May 07, 2020 |
|
Leadership - How to Measure & Motivate in a Startup Environment
|
Apr 30, 2020 |
|
Bobak Azamian CEO of Tarsus Addresses Unmet Needs in Blepharitis
|
Apr 23, 2020 |
|
Robert Dempsey New CEO of TearClear
|
Apr 16, 2020 |
|
Industry Insights into Innovation
|
Apr 13, 2020 |
|
Innovating Around the Globe
|
Apr 06, 2020 |
|
Collaborative Care in Cataracts & Ocular Surface Disease
|
Mar 30, 2020 |
|
Innovation Starts at Home
|
Feb 19, 2020 |
|
J&J Vision’s Newly Appointed Worldwide President of Surgical, Mr. Warren Foust Meets with OIS Podcast
|
Jan 14, 2020 |
|
J&J’s Tom Frinzi Provides Updates on Innovation Efforts & More
|
Sep 04, 2019 |
|
Mitro Opens Up About Aerie’s Programs
|
Jul 10, 2019 |
|
Novartis’ Patrick Mooney Gives Inside Look on the Impact of Alcon Spin-Out, Bid to Acquire Xiidra
|
May 14, 2019 |
|
Avedro CEO Reza Zadno Walks Us Through the Recent IPO, Reimbursement Wins, and Future Potential
|
Apr 24, 2019 |
|
Oculis CEO Riad Sherif Talks About Novartis, Alcon, and What’s Promising in His Company’s Pipeline
|
Apr 17, 2019 |
|
Oyster Point Pharma CEO Jeffrey Nau Highlights Details of the Company’s Recent B Round, Ponders IPO
|
Apr 10, 2019 |
|
Novaliq’s Bernhard Günther Reveals Company’s Fateful Start, Promising Future for Dry Eye Treatments
|
Apr 02, 2019 |
|
What Impact Will Gene Therapy Deals Have on Patients? Start-Ups? Jay Duker, MD, Can Speak for Both.
|
Mar 21, 2019 |
|
Wall Street Analyst David Nierengarten of Wedbush Dissects Recent Gene Therapy Shopping Spree
|
Mar 13, 2019 |
|
BONUS EPISODE: Direct from OIS@SECO - Industry Leaders Speaking Out on the Optometric Channel
|
Feb 28, 2019 |
|
Co-Chair James Thimons Walks Us Through the Highs and Even Highers of the First OIS@SECO
|
Feb 27, 2019 |
|
Former CMO Brian Levy Sits in the CEO Chair to Lead OcuNexus Down a Bold, New Biopharma Path
|
Feb 20, 2019 |
|
Ocutrx CEO Michael Freeman Honors a Promise to Develop AR Device That Could Help AMD Patients See
|
Feb 13, 2019 |
|
Paul Karpecki Sees ‘a Lot of Opportunity’ to Grow Treatment of Dry Eye and Other Ocular Diseases
|
Feb 05, 2019 |
|
Mark Blumenkranz Previews Upcoming Laser-Based Imaging Workshop, Updates on Big Data, Digital Tech
|
Jan 31, 2019 |
|
Justin Schweitzer, OD, of Vance Thompson Vision Talks Glaucoma, Dry Eye, and Clear Career Paths
|
Jan 24, 2019 |
|
Dry Eye Coach Hauser Shares Insights on New Treatments, Social Media and Working with Industry
|
Jan 16, 2019 |
|
Notal Vision CEO Susan Orr Presents a Clear Future for AMD Patients Conducting OCT Scans at Home
|
Jan 10, 2019 |
|
Eric Donnenfeld, MD, Handicaps a Crowded Field in the Race to Develop the Next Dry Eye Blockbuster
|
Dec 12, 2018 |
|
Chris Wroten, OD, Recalls Indirect Path into Eye Care, Sees Enormous Need for Upcoming OIS@SECO
|
Dec 05, 2018 |
|
Silverstein Traces His Path to Ophthalmology, Interest in Local Affairs, and Reliance of LIV
|
Nov 28, 2018 |
|
In our 200th Episode, IDx Founder Shares Wisdom from Recent Success with the FDA, Venture Investors
|
Nov 14, 2018 |
|
Web Vision Technologies CEO Bob Main Explains Why He’s Looking for The Right Stuff to Aid Astronauts
|
Nov 08, 2018 |
|
With Positive Phase II Dry Eye Data in Hand, What’s Next for Aldeyra’s Promising Pipeline?
|
Nov 01, 2018 |
|
Can Swiss Start-Up Ophthorobotics Develop a Robotics System to Deliver Intravitreal Injections?
|
Oct 31, 2018 |
|
Eyedaptic CEO Jay Cormier Lays Out Start-Up’s Vision for Augmented Reality Visual Restoration Device
|
Oct 03, 2018 |
|
Simple Contacts CEO Joel Wishkovsky Says Start-Up’s App Could Upend Vision Care
|
Sep 26, 2018 |
|
James Thimons, OD, Discusses Technology’s Positive Impact on Diagnosing and Treating Eye Disease
|
Sep 20, 2018 |
|
Glaukos COO Calcaterra Lays out Pipeline Plans Following iStent inject OK, Reacts to CyPass Recall
|
Sep 13, 2018 |
|
Louis Pasquale Discusses Eyenovia’s Trial, Other Causes of Glaucoma, and the Promise of Telemedicine
|
Aug 24, 2018 |
|
Peter Menziuso, JJV President, North America Vision Care, Lobbying for Protections in the Contact Lens Rule
|
Aug 22, 2018 |
|
REGENXBIO CEO Ken Mills Shines Light on Promising Phase I Trials for Wet AMD Gene Therapy RGX-314
|
Aug 15, 2018 |
|
Doug Foster, Chief Strategy Officer of Verana Health, Explains Plans to Replicate IRIS Partnership
|
Aug 08, 2018 |
|
Did You Miss OIS Retina (or Just Miss Being in Vancouver?) Hear Highlights from the Meeting Floor
|
Aug 02, 2018 |
|
Skimming the Ocular Surface with TFOS’ Amy Gallant Sullivan and Purdue Researcher Chi Hwan Lee
|
Jul 18, 2018 |
|
Oyster Point Pharma CEO Nau Takes a Deeper Dive into Just-Released PEARL Trial Results
|
Jul 12, 2018 |
|
John Berdahl Speaks on the Importance of Mentors and Changing Views on How to Treat Glaucoma
|
Jun 27, 2018 |
|
Surgeon/Engineer Steve Charles Has Advice for Aspiring Inventors: Never Stop Learning; Dump Netflix
|
Jun 13, 2018 |
|
CEO Sean Ianchulev Shares Eyenovia's Plans to Replace Eye Drops with New Microdosing Technology
|
May 31, 2018 |
|
OIS Podcast Update on Dry Eye and MGD - What's Up at J&J, Oyster Point and Tear Film Innovations?
|
May 23, 2018 |
|
OIS Podcast Finds Out What's Next for Nicox and Zeiss in Two Talks with Michele Garufi and Jim Mazzo
|
May 16, 2018 |
|
OIS Podcast Talks Fund-raising with Avedro's Reza Zadno, Innovation with Allergan's Bill Meury
|
May 10, 2018 |
|
Dry Eye Coach Hauser Speaks to How New Tech - Including Social Media - Can Bolster a Practice
|
Apr 04, 2018 |
|
AcuFocus President Al Waterhouse Explains Company's Decision to Sell Kamra Inlay to Focus on IOLs
|
Mar 29, 2018 |
|
SightLife Surgical CEO Monty Montoya Says Start-Up Is Building Out Cornea Market
|
Mar 22, 2018 |
|
CEO David Muller Says Allotex Looks to Create Living Contact Lens with Corneal Allograft
|
Mar 14, 2018 |
|
AGTC's Washer on What it Means to Join BIO Board
|
Feb 28, 2018 |
|
Shire's Dempsey Highlights Global Leader's Early Bet in Optometry, Role in Upcoming OIS Launch
|
Feb 23, 2018 |
|
Hear Details on Feb. 28 Dry Eye Dinner at SECO, Interview with J&J's Dry Eye Head, Joe Boorady
|
Feb 14, 2018 |
|
New CEO Mattessich Brings in New Skills, Leadership to Help Ocular Therapeutix Reach Potential
|
Feb 07, 2018 |
|
Pixium Vision CEO Sees a Day When Wireless PRIMA Implant Could Bring Vision Back to AMD Patients
|
Jan 31, 2018 |
|
We Ask Analysts How Will Pharma and Medtech Companies Spend Billions in Repatriated OUS Profits?
|
Jan 25, 2018 |
|
Life After the IPO: What Does Apellis Have Planned After Raising $170m from Public Investors?
|
Jan 17, 2018 |
|
Drug Pricing Pro Roger Longman of Real Endpoints Says Spark Therapeutics Is Making the Right Moves
|
Jan 10, 2018 |
|
Oyster Point Pharma CEO Jeff Nau Taps Experience, Successful Network to Build Dry Eye Start-up
|
Jan 04, 2018 |
|
Using AI to Improve Diagnosis of Disease
|
Dec 13, 2017 |
|
Part II: OIS Co-chair Emmett Cunningham, Jr. Delivers Annual Overview on the State of Ophthalmology
|
Dec 06, 2017 |
|
OIS Co-chair Emmett Cunningham, Jr., MD. Delivers Annual Overview on the State of Ophthalmology
|
Nov 29, 2017 |
|
Dry Eye Diaries: Hear Tales and Hopes from Leaders of Shire, Johnson & Johnson, and TearSolutions
|
Nov 21, 2017 |
|
CEO Brent Saunders Lays out Allergan’s Plans for Ophthalmology, Restasis, and Innovation
|
Nov 15, 2017 |
|
Donnenfeld, MD, Talks Blue Sea PE Deal, OD/MD Collaboration, and Why OCLI Got CheckedUp
|
Nov 07, 2017 |
|
OIS Co-Chair Emmett Cunningham Walks through the Upcoming OIS@AAO Agenda, Reveals New Ways to Engage
|
Nov 01, 2017 |
|
Aerie CEO Anido Talks War Rooms, FDA, Rhopressa, Roclatan, and Getting Along with the Neighbors
|
Oct 25, 2017 |
|
Gemini CEO McLaughlin Explains How the Precision Therapeutics Start-up Will Take Aim at Eye Disease
|
Oct 18, 2017 |
|
What’s Next PanOptica? We Ask CEO Chaney
|
Oct 11, 2017 |
|
ExSight Capital, Partner Firas Rahhal, MD, Are Building a Successful Record as Impact Investor
|
Oct 04, 2017 |
|
Dr. Pravin Dugel Picks Possible Winners in Race to Deliver New Retinal Treatments
|
Sep 28, 2017 |
|
Hatteras’ Shaffer Found a Model That Works at Inspire; Now She Uses It When Making Investments
|
Sep 20, 2017 |
|
Digital Health Is Dead? Don’t Tell Mark Blumenkranz, the FDA, or the Organizers of an Oct. Workshop
|
Sep 13, 2017 |
|
What Was the Most Difficult Part of Successfully Transitioning to CMO? We Ask B&L’s Cal Roberts
|
Sep 06, 2017 |
|
Imperial College’s Dr. Cordeiro Explains How DARC May Bring Early Light to Disease, Shorten Trials
|
Aug 28, 2017 |
|
Why Did Charles Semba, MD, Switch Specialties and How Did He Find a Home in Ophthalmology?
|
Aug 23, 2017 |
|
OIS@ASRS Co-Chairs Give High Marks and Hopes for Innovators Looking at the Back of the Eye
|
Aug 16, 2017 |
|
What Does TearScience Deal Mean for J&J? Group Chair Ashley McEvoy Shines Light on Future Plans
|
Aug 08, 2017 |
|
Should You Be at OIS@ASRS on Thursday? Take an Insider Look at the Agenda with Emmett Cunningham
|
Aug 08, 2017 |
|
Allegro’s Poised to Deliver Positive News at ASRS; Could an IPO Be Next? We Ask Vicken Karageozian
|
Aug 02, 2017 |
|
Double Shot: Two Leading Ophthalmologists Discuss the Impact Innovation Is Having on Eye Care
|
Jul 26, 2017 |
|
Investor, Executive Shine Light on Private Equity’s Growing Interest and Influence in Ophthalmology
|
Jul 18, 2017 |
|
Sun Pharma’s St. Peter Outlines Company’s Ambitious Plan to Build Ophthalmology Pipeline
|
Jul 11, 2017 |
|
Alcon's Attias Touts Growing Pipeline Including Progress in Glaucoma and Google Projects
|
Jul 05, 2017 |
|
NEA's Behbahani, with New Fund to Invest, Discusses VC's Strong Interest in Ophthalmology
|
Jun 27, 2017 |
|
Implandata Co-Founder Outlines Next Step as Company Scores CE Mark for Continuous IOP Monitoring Device
|
Jun 21, 2017 |
|
Mynosys CEO Hendrick Lays Out Next Step for Zepto Following Positive FDA, Strong OUS Launch
|
Jun 14, 2017 |
|
Donnenfeld Discusses How New Diagnostics, Treatments Impact His Practice and Patients
|
Jun 07, 2017 |
|
COO Tom Mitro Discusses Aerie’s Preparation for Rhopressa Launch, Updates OIS@ASCRS on Pipeline
|
May 31, 2017 |
|
CEO Ludwin Monz Discusses Zeiss’ Important Management Hires, SMILE, and the Future of Diagnostics
|
May 24, 2017 |
|
Alice Epitropoulos, MD, on How Xiidra, TrueTear, and Other Treatments Impact Practices, Patients
|
May 18, 2017 |
|
CEO Ram Rao Discusses Juvene, the Rise of Presbyopia, and How LensGen Raised $21 million
|
May 10, 2017 |
|
In an Insightful Wrap-up, OIS Co-chairs Share the Top Takeaways from another Successful OIS@ASCRS
|
May 07, 2017 |
|
Can OIS Help Make Myopia Great Again? Co-chair Kliman Discusses Inventive New Panel, Opportunities
|
Apr 27, 2017 |
|
Award Winner Korroch Explains How Eye Banks Have Worked to Ensure Supply Exceeds Demand
|
Apr 20, 2017 |
|
What’s the Difference between Creativity and Innovation? Blumenkranz Answers That and Much More
|
Apr 12, 2017 |
|
OIS Co-Chair Bill Link Walks Us Through OIS@ASCRS May 4 Agenda and Introduces Flying L Partners
|
Apr 05, 2017 |
|
Prolific Investigator Thompson Gives His Take on SMILE, Cross-Linking, Oculeve, and Other Innovations
|
Mar 29, 2017 |
|
Co-author Thomas Albini, MD, Explains Why Eye Docs Wrote NEJM Paper to Expose Stem Cell Injuries
|
Mar 22, 2017 |
|
Nancy Lurker Discusses Bringing Her Commercial Experience, Insights to Drug Delivery Upstart pSivida
|
Mar 15, 2017 |
|
We Ask Dick Lindstrom What Practice Consolidation May Mean for Ophthalmology, Innovation (Pt. 2)
|
Mar 08, 2017 |
|
Dick Lindstrom Tells us why Minnesota Eye Consultants Partnered With a Private Equity Firm (Pt. 1)
|
Mar 01, 2017 |
|
Apellis CEO Delivers Some Hopeful Pipeline News, and Offers a Cautionary Note on Immigration Debate
|
Feb 23, 2017 |
|
Eyes Up! NEI Challenges “Solvers” to Create 3D Retina Organoid that Could Aid Research
|
Feb 15, 2017 |
|
Abbie Celniker Shares Her View of Pharma, Ophthalmology from High-flying Third Rock Ventures
|
Feb 09, 2017 |
|
Can Presbyopia Therapies Deliver an Encore with its Own Vision-Correcting Eye Drops?
|
Feb 02, 2017 |
|
Novartis Sees Clear Opportunity in Encore Vision’s Unique Approach to Correcting Presbyopia
|
Jan 27, 2017 |
|
Looking Beyond the Tweets: What Trump’s Pharma Pricing Pledge Might Mean for Ophthalmology
|
Jan 18, 2017 |
|
Novaliq’s Positive Phase II Dry Eye Results Present Break from Disappointing Clinical Trial Season
|
Jan 12, 2017 |
|
EyeGate Pharma Discusses Early Clinical Trials Success, Promising Pipeline, and Partnership Payouts
|
Jan 06, 2017 |
|
What Now? What Does Ophthotech’s Disappointing Phase III Results Mean for Wet AMD, VEGF and PDGF?
|
Dec 16, 2016 |
|
Can Lighting Strike Twice? SARCode’s Co-Founder Gadek Takes Helm of Promising Dry Eye Start-up
|
Dec 07, 2016 |
|
Andrew Chang Discusses His Move to Lead Global Sales of Zeiss Meditec’s Ophthalmic Devices
|
Nov 30, 2016 |
|
What Are Tom Frinzi’s Plans after J&J Acquires AMO? Frinzi Talks J&J, Symfony, and Much More
|
Nov 22, 2016 |
|
OIS Editorial Roundtable: What Impact Will a Trump Administration Have on Ophthalmology?
|
Nov 16, 2016 |
|
Carl Zeiss’s Jim Mazzo Talks About Failing Fast, the Reply All Button and Reaching the Customer
|
Nov 09, 2016 |
|
How it All Began. Allergan’s Herbert Shares Details of His Contribution to Ophthalmology’s Origins
|
Nov 01, 2016 |
|
David Pyott on Growing Allergan, Defending Against Acquisitions, and How the Next Chapter Will Read
|
Oct 27, 2016 |
|
Live (sort of) from Chicago: OIS Podcast Brings You the Voices of OIS@AAO
|
Oct 20, 2016 |
|
Introducing Our Newest Tool – the OIS Index
|
Oct 12, 2016 |
|
OIS Founder & Co-Chair Emmett Cunningham Jr. Tells Us What to Watch for Next Week in Chicago
|
Oct 05, 2016 |
|
Hear How Preceyes Will Help Usher Robotics into Ophthalmic Surgery
|
Sep 28, 2016 |
|
Behind the Deal: McEvoy On Where Will AMO Fit into J&J & What the Deal Means for Eye Care
|
Sep 21, 2016 |
|
Live (sort of) from Copenhagen: OIS Podcast Hits the High Points of ESCRS and EuRetina
|
Sep 15, 2016 |
|
Xiidra Prior to Shire: How SARcode Took on the Odds to Pursue a New Treatment for Dry Eye
|
Sep 08, 2016 |
|
A note from OIS Podcast
|
Sep 01, 2016 |
|
100th Episode & Counting
|
Aug 25, 2016 |
|
CEO John Kilcoyne Reviews ReVision’s Success with the FDA & its Plans to Roll Out Raindrop
|
Aug 18, 2016 |
|
Live from the Floor of OIS@ASRS: Co-Chair Bill Link on What Made the Day Work So Well
|
Aug 11, 2016 |
|
What Will Carl Zeiss Meditec’s New Ophthalmology Unit Look Like? We Ask Jim Mazzo.
|
Aug 03, 2016 |
|
Clearside Biomedical Finds the Public Markets Despite Diminished Interest in Sector
|
Jul 26, 2016 |
|
Can Allegro’s Integrin Peptide Therapy Help Usher in Retina 2.0 for Vitreoretinal Indications?
|
Jul 20, 2016 |
|
Godspeed Xiidra. Shire’s Robert Dempsey Introduces the Newest FDA-Approved Treatment for Dry Eye.
|
Jul 12, 2016 |
|
What Drives Innovators? Pioneer Mark Humayun, MD, PhD, Shares His Story & Vision for Ophthalmology
|
Jul 06, 2016 |
|
A Walk Down Wall Street: Two Analysts Tell You What to Expect From the Markets in the Coming Months
|
Jun 29, 2016 |
|
Steven Vold, MD, Sees Enormous Potential in Coming Tide of IOLs, Diagnostics & Potential New Drugs
|
Jun 22, 2016 |
|
Aldeyra CEO Highlights Clinical Trial Success of Possible Treatments for Conjunctivitis, Uveitis
|
Jun 15, 2016 |
|
Ludwin Monz, PhD, Discusses Zeiss, its Legacy & Where it Pursues New Innovation
|
Jun 08, 2016 |
|
Bausch & Lomb’s CMO Cal Roberts on How He Uses His MD & Experience to Build the Right Tool Kit for Ophthalmologists
|
May 31, 2016 |
|
Dempsey on Building the Shire Brand in Ophthalmology
|
May 24, 2016 |
|
OISPodcast@ASCRS - Meury: Why Allergan Won’t Miss a Beat in Building Ophthalmology Franchise
|
May 19, 2016 |
|
What the Heck Happened at OIS@ASCRS?
|
May 15, 2016 |
|
Graybug Vision – Flush with Cash – Is Making Big Moves to Change its Approach to Finding New Treatments for Wet AMD & Other Eye Disease
|
May 03, 2016 |
|
Sun Ophthalmics Looks to Build a Brand-New Business in the US
|
Apr 28, 2016 |
|
Avedro’s Long Wait for FDA Approval is Over
|
Apr 20, 2016 |
|
What are Allergan’s Next Steps?
|
Apr 13, 2016 |
|
KOL Corner: Can Complement Inhibitors Treat Macular Degeneration?
|
Apr 06, 2016 |
|
Frinzi shares a bit of his plans for AMO
|
Mar 29, 2016 |
|
Can Apellis Find a Way to Inhibit the Complement System & Treat Intermediate AMD?
|
Mar 24, 2016 |
|
Lewis Handicaps MIGS Market and Explains Glaucoma’s Emergence
|
Mar 16, 2016 |
|
VisionCare Battling Back against Macular Degeneration
|
Mar 09, 2016 |
|
Heier Talks Anti-Angiopoietin Programs, Clinical Trials & Red Sox
|
Mar 02, 2016 |
|
KOL Corner: Alcon, Transcend & Glaucoma 360
|
Feb 25, 2016 |
|
What Does the Leadership Shuffle Mean for Ophthalmology?
|
Feb 18, 2016 |
|
EyeGate Finds New Paths to Dollars, Deal
|
Feb 11, 2016 |
|
Muller Explains Departure from Avedro; Opportunity in New Venture
|
Feb 03, 2016 |
|
Inotek’s Southwell and McVicar Have Designs on Treating Glaucoma
|
Dec 16, 2015 |
|
Emptying the OIS Reporter’s Notebook After OIS@AAO
|
Dec 09, 2015 |
|
Where Will `Pfizergan’ Fit in Ophthalmology
|
Dec 01, 2015 |
|
Aura Biosciences Offers Hope for Ocular Melanoma
|
Nov 23, 2015 |
|
A Rundown of a Record-setting OIS
|
Nov 19, 2015 |
|
Celniker Gets Eleven Bio Ready For OIS and Conference Season
|
Nov 09, 2015 |
|
Ora’s Ousler Delves Deep into Dry Eye
|
Nov 02, 2015 |
|
Muller on the FDA, PIXL and Dairy Farms
|
Oct 28, 2015 |
|
Biogen’s High Hopes For Gene Therapy, Ophthalmology
|
Oct 21, 2015 |
|
Understanding Market Cycles: When Could Biotech UnBoom?
|
Oct 13, 2015 |
|
Can Spark Phase III Results Ignite Gene Therapy?
|
Oct 08, 2015 |
|
Implandata's Hands-On Approach To Tracking IOP
|
Sep 30, 2015 |
|
Sadri: How MIGS And Other New Tech May Change His Practice
|
Sep 23, 2015 |
|
OcuSciences Hopes to Give Early Warning on Ocular Disease
|
Sep 16, 2015 |
|
Imprimis’ Baum on Disrupting Compound Pharmacies
|
Sep 09, 2015 |
|
Opthea Exploring Different Approach To Treating Wet AMD
|
Aug 31, 2015 |
|
Makower: Making Medtech Bigger, Stronger, Faster
|
Aug 26, 2015 |
|
ClarVista’s Two-Part Strategy To Premium IOLs
|
Aug 19, 2015 |
|
CEO Tom Burns Has Even Bigger Plans For Glaukos
|
Aug 12, 2015 |
|
Year 1: What OIS Podcasts Were Most Popular? Part Two
|
Aug 05, 2015 |
|
Year 1: What OIS Podcasts Were Most Popular?
|
Jul 29, 2015 |
|
A Favorite From The OIS Podcast Stack
|
Jul 21, 2015 |
|
Clarus Delivers Good News With $500m Fund
|
Jul 14, 2015 |
|
Oculeve Open Ups, Just a Little, on OD-01
|
Jul 08, 2015 |
|
Hear Bausch & Lomb’s Ophthalmology Play Book
|
Jun 30, 2015 |
|
A discussion of Allergan’s legacy and future in Medtech Ophthalmology
|
Jun 23, 2015 |
|
Here is How Big Companies Innovate
|
Jun 15, 2015 |
|
Hear How Valeant Innovates, Invests and Acquires
|
Jun 10, 2015 |
|
Transcend Medical Ready To Make Move In MIGs
|
Jun 02, 2015 |
|
Borrmann Gives View Into AMO’s Innovation Cycle
|
May 26, 2015 |
|
OIS Optical Overview: Haimovich, Lachman Share Insights On OIS, MIGs, IOLs, etc.
|
May 19, 2015 |
|
Avedro CEO Muller Answers Questions about the FDA’s Questions
|
May 12, 2015 |
|
Lindstrom Wins Ophthalmology Innovator Award
|
May 04, 2015 |
|
Mazzo Details Plans For Kamra Inlay’s Introduction To The US Following FDA Approval
|
Apr 27, 2015 |
|
Alternative Financing Approaches
|
Apr 21, 2015 |
|
PowerVision’s Cheskin discusses the potential of the company’s accommodating IOL, FluidVision
|
Apr 13, 2015 |
|
Alphaeon’s Grant Explains Innovative New Model
|
Apr 07, 2015 |
|
Co-Chair Link Gives Overview of Upcoming OIS
|
Mar 31, 2015 |
|
Alcon’s Attias Offers Insights on Innovation
|
Mar 24, 2015 |
|
Holland Delivers Overview of ASCRS, Ophthalmology
|
Mar 16, 2015 |
|
Talley Rostov Works to Improve Global Vision
|
Mar 10, 2015 |
|
Blumenkranz Shares His Success, Failures And New Opportunities For Ophthalmic Innovators
|
Mar 02, 2015 |
|
Alcon’s Plan For WaveTec’s ORA System
|
Feb 24, 2015 |
|
CEO Russ Trenary Discusses InnFocus’ Push into the Competitive MIGs Market
|
Feb 17, 2015 |
|
Ophthalmology By The Numbers With Jon Norris of SVB
|
Feb 09, 2015 |
|
DigiSight Puts Eye Care in Patients’ Hands
|
Feb 03, 2015 |
|
Vance Thompson, MD, Speaks to Importance of Patient “Experience” in a successful practice.
|
Jan 27, 2015 |
|
A multi-generational look at ophthalmology with Dr. George O. Waring IV
|
Jan 20, 2015 |
|
Second Sight Fulfills Dream
|
Jan 13, 2015 |
|
Eleven’s Celniker Talks Leadership, Public Markets, and Phase III Dry Eye Trials
|
Jan 06, 2015 |
|
Cunningham: 2015 Could Be A Big Year For Ophthalmology
|
Dec 16, 2014 |
|
TearScience CEO Willis Explains Dry Eye Disease’s Emergence
|
Dec 09, 2014 |
|
Alimera CEO Myers Shares Lessons From Iluvien FDA Approval
|
Dec 02, 2014 |
|
Opening The Door For Premium IOLs
|
Nov 24, 2014 |
|
Ocular Therapeutix Starting to Sprint
|
Nov 17, 2014 |
|
Alcon Head Jeff George Lays Out Vision
|
Nov 11, 2014 |
|
How Thoughtful Consolidation Can Benefit Ophthalmology
|
Nov 03, 2014 |
|
How Alcon and Google Could Change the Contact Lens
|
Oct 28, 2014 |
|
NASA-Backed Entity Enlists Industry To Battle Eye Disorders Caused By Space Travel
|
Oct 21, 2014 |
|
Dirk Sauer Oversees Novartis’ Promising And Productive Ophthalmic Pipeline
|
Oct 13, 2014 |
|
Gobiquity Goes Big In Mobile Imaging Diagnostics
|
Oct 07, 2014 |
|
Anido Guides Aerie’s Push To Be A “Very Big Player” In Glaucoma
|
Sep 29, 2014 |
|
Slade Discusses the Opportunities, and Challenges, of New Technology.
|
Sep 22, 2014 |
|
Hear How Avedro’s Muller Is Building A Cross-Linking Powerhouse
|
Sep 15, 2014 |
|
Ophthalmology Is A “Leading Franchise” At InterWest
|
Sep 09, 2014 |
|
Lindstrom: Ophthalmologists Facing Both Opportunity And Pressure
|
Sep 02, 2014 |
|
Cunningham: Strong Signs Ahead For Ophthalmology Innovation
|
Aug 25, 2014 |
|
Donnenfeld Bullish on Ophthalmic Innovation
|
Aug 18, 2014 |
|
Link Says Versant's Eyes Will Be on Ophthalmology
|
Aug 12, 2014 |
|
Mazzo Muses on the FDA, Google and Failing Fast
|
Aug 04, 2014 |